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ABSTRACT 
 
 
Jessica Laurin Holloman: The Effect of the IsoliteTM Suction on Aerosols and Splatter During 
Ultrasonic Scaling 
(Under the direction of Sally Mauriello) 
 
  
 This study compared the IsoliteTM and saliva ejector on aerosol reduction during 
ultrasonic scaling. Fifty participants were randomly assigned to control (n=25, saliva ejector) or 
test groups (n=25, IsoliteTM). Plaque extent scores were recorded and aerosols were collected 
both during (timed period) and post (35 minute period) ultrasonic scaling in buffer in Petri dishes 
placed six inches from the participant’s mouth. Participants were surveyed regarding device 
acceptance. The during and post suspensions were plated to blood agar plates and recoverable 
colonies (CFU) were counted following anaerobic incubation. Significant contamination 
occurred during ultrasonic scaling in both device groups, as indicated by high CFU and the 
identification of strict oral anaerobes on all plates. A Student t-test revealed that the test device 
did not reduce aerosol contamination compared to the control device (p=0.25). Additional 
caution should be exercised with these devices to reduce the risk of exposure to potential 
pathogens.  
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CHAPTER 1: INTRODUCTION 
 
 
 According to the Centers for Disease Control and Prevention (CDC), almost all new 
infections in the United States are contracted through the aerosol route from infected patients 
who are coughing and dispersing infective droplet nuclei into the air.1 Therefore, the presence 
and dispersal of aerosols and splatter are a concern in healthcare due to their potential adverse 
health effects on patients and healthcare workers. The effect of these aerosols on 
immunocompromised patients is concerning due to their increased susceptibility to the 
potentially infectious bacteria that are present in these aerosols.  Many routine dental procedures 
produce aerosols and splatter, which may contain infectious material such as blood, saliva, and 
other organic matter.2 Published data showed that ultrasonic scalers, as well as other types of 
dental hand pieces, had a significant effect on the number of colony-forming units (CFU) 
cultivable from the air when compared to preprocedural levels.3, 4 The ultrasonic scaler, in 
particular, has been shown to produce three times the bacterial aerosol contamination as that 
produced by dental operative equipment.1,5 Based on supportive data, the American Dental 
Association (ADA) has recommended that the high-volume evacuator (HVE) be employed 
during the use of ultrasonic scalers to minimize the spread of airborne bacterial contamination 
during ultrasonic scaling.6,7 This recommendation creates a unique challenge for dental health 
care workers, specifically dental hygienists, that traditionally provide clinical care without a 
dental assistant.  Due to the nature of most suction devices, dental hygienists must sacrifice their 
non-dominant hand, as well as light and indirect vision, while using the ultrasonic scaler. 
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Further, the HVE can be bulky and difficult to maneuver when an assistant is not available, 
making the saliva ejector the device of choice to remove excess fluids from the oral cavity. The 
IsoliteTM dryfield illuminator, a product created with “hands-free” dentistry in mind, was 
introduced to the commercial market in 2005.8 The primary purpose of this system is to provide 
isolation and illumination to the oral cavity, but has been purported to have an added benefit of 
aerosol reduction by as much as 65% when compared to the saliva ejector in a simulated clinical 
environment.8,9 There is currently no published data on how the IsoliteTM compares to the saliva 
ejector when used with an ultrasonic scaler in an actual clinical environment. Further, there is no 
published literature regarding patient acceptance of the IsoliteTM in an adult United States 
population.  
 After reviewing the literature and developing the protocol for the current study it seemed 
prudent to attempt to identify an alternative methodology for the collection and quantification of 
aerosols and splatter. The methods available often included the use of equipment that was either 
expensive or not readily available and these methods typically did not include both the 
quantification of aerosols and splatter and identification of specific bacteria collected. 
Therefore, the purpose of this study was two-fold:  
(1) Compare the effect of the IsoliteTM suction and saliva ejector on aerosols and splatter during 
ultrasonic scaling, and 
(2) Determine patient acceptance of the IsoliteTM in an adult U.S. population. 
Additional specific objectives included:  
(3) Develop an alternative methodology to collect and quantify aerosols and splatter, and 
(4) Confirm that recovered bacteria originated from an oral source. 
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CHAPTER 2: A REVIEW OF THE LITERATURE 
 
Introduction 
 
 Since the 1960’s, the detrimental effects of aerosols and splatter and their role in the 
spread of infectious diseases have been extensively researched and documented. The role of 
aerosols and splatter in the spread of infectious diseases have been linked to outbreaks of 
influenza, chickenpox, tuberculosis (TB), legionnaire’s disease, severe acute respiratory 
syndrome (SARS), etc.1,5,6  It is known that the transmission of these diseases occurs via the 
airborne route from human sources through the inhalation of droplet nuclei that are aerosolized 
by respiratory secretions such as coughing, sneezing, or talking.10 Aspiration of pathogenic 
bacteria from the oral cavity has also been linked to certain systemic infections.11,12 Pneumonia, 
an infection of the lungs, has been extensively studied and is most common in an 
immunocompromised population, such as the elderly.13  
 In order to address the control of potentially infectious aerosols it was necessary to first 
examine their characteristics and capabilities. Assessment of aerosols and splatter included 
factors such as generation, particle size and concentration, infectivity and virulence, viability, air 
flow, environmental sampling, and analysis.10 These factors have been studied and reported by a 
range of experts, including those who specialize in aerobiology to dentists who were interested in 
reducing the presence of aerosols and splatter in the dental office. The spread of aerosols and 
splatter were first appraised by exploring their history in healthcare and dentistry and their 
impact on healthcare workers. 
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This was followed by identifying those procedures known to produce the greatest amounts of 
aerosols and splatter, which has proven key in the process of sampling and studying the 
microorganisms that are linked to the spread of infectious diseases. Finally, the mechanisms to 
control the spread of aerosols and splatter are the final piece to preventing their dissemination in 
the dental office.  
Defining Aerosols and Splatter 
 
  Although the Occupational Safety and Health Administration (OSHA) does not 
explicitly define aerosols according to size, the consensus among the literature states that 
aerosols can be liquid or solid particles that are approximately 50µm or less in diameter, are 
suspended in the air, and are capable of penetrating deep into the respiratory system.3,14,15,17 
Previous aerobiology studies have shown that aerosols tend to stay airborne for an extended 
period of time before they settle on surfaces or enter the respiratory tract. 3,10,17,18 It is the smaller 
particles of an aerosol (.5µm -10µm in diameter) that are of particular concern because they are 
thought to carry the greatest potential for transmitting infections due to their ability to penetrate 
and lodge into the smaller passages of the lungs.5  
 Splatter particles differ from aerosols because they are visible to the naked eye and are 
considered too large to be inhaled and imposed deep within the lung.3,16  Splatter particles are 
known to behave in a ballistic manner, in that they follow an arc trajectory from the oral cavity 
until they contact a surface.15 It is because of this trajectory that splatter particles do not remain 
suspended in the air for long periods of time, making them less likely to transmit disease via the 
airborne route. 
 Another important consideration when discussing aerosols and splatter is the viability of 
the microorganisms within the environment once they have left the host. The viability of the 
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microorganism is essentially the ability of the microorganism to reproduce. When 
microorganisms leave their host and are aerosolized, they are potentially injured during the 
generation process.10 Previous data have shown that microorganisms could remain viable in the 
airborne state for long enough to permit their wide dissemination.19 Factors such as temperature, 
relative humidity, air flow, and oxygen sensitivity will impact whether or not microorganisms 
are able to survive outside of the host and replicate.19 Engineering controls should be in place 
within healthcare settings to eliminate these microorganisms and limit the exposure of the staff 
and public to their presence. It is necessary to understand the factors related to aerosol and 
splatter generation and survival when considering disease transmission. This knowledge is 
crucial to the task of implementing protocol for the elimination of aerosols and splatter, therefore 
preventing disease transmission.  
Aerosols and Healthcare 
 
With regard to healthcare workers, OSHA stated that the primary routes of infectious 
disease transmission in U.S. healthcare settings are through contact, droplet, and airborne 
particles.1,6  Airborne diseases such as tuberculosis, influenza, measles, chickenpox, and 
Legionnaires’ disease have been well documented as capable of remaining viable and airborne 
within the indoor environment.20,21-24 The ability of aerosols to remain suspended in the air and 
disperse over considerable distances increases the likelihood of cross-contamination.25 Because 
of these characteristics, it is not surprising that healthcare workers and patients are at an 
increased risk of infection.   
 In cases where measles and tuberculosis have been spread in an indoor environment, 
airflow studies revealed that droplet nuclei were generated throughout the entire office.24, 26 
Legionnaire’s disease, a severe form of pneumonia, is also spread via the aerosol route. This 
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disease is estimated to infect 10,000 to 15,000 persons per year in the United States, where 9% of 
cases occur at least six months before or after a hospital outbreak.23 This disease has become 
especially concerning in dentistry due to its link to dental unit waterlines (DUWL).4,19,23 Another 
systemic infection that has been extensively studied is pneumonia. This infection is especially 
common in the elderly and can be acquired from cross-contamination or self ingestion.13 
Aspiration pneumonia, a type of pneumonia caused by the inhalation of a substance into the 
lung, is often associated with anaerobic bacteria.11 This type of pneumonia is especially likely 
during dental procedures, which can yield high amounts of bacteria laden aerosols and splatter.  
Based on this knowledge, the presence and dispersal of aerosols in indoor environments 
are a growing concern in epidemiology.25, 27 Further, special patient populations, such as the 
immunocompromised patient, have been shown to be at a greater risk of infection than the 
average healthy patient.20  
Aerosols and Dentistry 
 
 In the dental clinic, aerosols are of particular concern due to the inherent nature of most 
dental procedures. Studies have demonstrated that many routine dental procedures that 
incorporate the use of water sprays or rotary instruments artificially generate aerosols that 
produce significantly greater numbers of bacteria than those activities produced by non-dental 
related oral activities, such as coughing and sneezing.17, 28 In a review of the literature by Harrell 
et al., it was emphasized that saliva and nasopharyngeal secretions may contain pathogenic 
organisms such as herpes viruses, streptococci, staphylocci, and the SARS virus.85,29 Further, 
bloodborne diseases such as Hepatitis and Human Immunodeficiency Virus (HIV) can be 
transmitted into the air via blood droplets.5,29  
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 In addition to the transmission of infectious diseases, aerosols can be a source of irritants, 
allergens, and other toxic substances, which are a potential source of acute or chronic respiratory 
disease.17 A survey of aerosol-related symptoms in dental hygienists who frequently use 
ultrasonic scalers revealed that symptoms such as nasal irritation, persistent cough, runny eyes, 
itchy and dry skin, were more common in dental hygienists than in nurses and hospital staff.30 
Dental staff must consider protecting themselves and their patients from common airborne 
diseases and infectious diseases that are not characteristically airborne and are being transmitted 
into the air during dental procedures. The inhalation of these substances may not be of concern to 
the average healthy patient, but special patient populations, such as the immunocompromised 
patient, can be especially susceptible to the adverse effects of these aerosols. Both the CDC and 
the ADA have recommended reducing the risk of infection posed by aerosols by the use of 
rubber dams, high-velocity air evacuation, and proper patient positioning, along with standard 
precautions.1 Based on the evidence surrounding the generation of water spray by the ultrasonic 
scaler, one may infer a relationship between the production of infectious aerosols and treatment 
techniques. Thus, mechanisms to reduce aerosol spray should be considered during ultrasonic 
instrumentation. 
The Ultrasonic Scaler 
 
 Those dental procedures shown to create high amounts of aerosols and splatter are of 
particular concern in oral epidemiology. Hand scaling, for example, has been shown to create 
negligible amounts of aerosol and splatter.2 Ultrasonic scalers and high-speed hand pieces have 
been studied extensively and were shown to produce measurable amounts of aerosols and 
splatter.2, 6,16,17,28,31,32,42 Since the water spray emitted from the working tip of an ultrasonic 
scaling hand piece bears a strong physical resemblance to the spray of high-speed dental hand 
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piece, many studies have advised the same type of aerosol reduction device.33 A dental hygienist 
commonly uses ultrasonic scalers during periodontal instrumentation and routine prophylaxis. 
These devices utilize high-frequency vibrations and water as a medium of ultrasonic energy to 
remove calculus deposits and have been labeled as one of the major sources of potential aerosol 
contamination in the dental setting due to the large amount of aerosols expelled into the air 
during their use.9, 33  
Reduction of Aerosols and Splatter  
 
Abundant research is available regarding the presence and dispersal of aerosols and 
various devices have been evaluated regarding their effectiveness.2-5, 16,20,31,33-36 Traditional 
methods that reduce potentially infectious aerosols during dental procedures include the low and 
high-volume evacuator, dental dam, pre-procedural rinses, and various air quality devices.2, 
8,16,31,35-37   A landmark study conducted by Micik et al. in 1969 was published regarding the 
reduction of aerosols during routine dental procedures and found that the HVE demonstrated the 
highest efficiency.15  Since then, various studies have shown that when compared to no suction 
or the saliva ejector the HVE has proven to be the most effective at reducing aerosols created 
during dental procedures by as much as 90%.14,15,34-36  The use of a rubber dam has also been 
shown to eliminate almost all contamination that arises from saliva or blood, but this type of 
device is not feasible for most periodontal and dental hygiene procedures. 32,37,38 During most 
dental procedures, it is the assistant who manipulates the HVE due to the manner in which it 
must be used to properly control aerosol and splatter. The HVE can be cumbersome and 
uncomfortable to the patient and clinician if not used correctly. These actualities make the HVE 
difficult to use as a single clinician, which is often the case during procedures rendered by a 
dental hygienist.  
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  In 1996, Harrel et al. published an in vitro study, which primarily investigated the 
reduction of aerosols and splatter with the use of an HVE attachment compared to no suction 
during use of the ultrasonic scaler.34 Recognizing the limitations of the HVE, a sheath was 
engineered to connect the HVE to the ultrasonic scaler. To assess aerosol reduction, a plastic 
enclosure with one centimeter square gridlines was assembled to enclose around a dentoform 
model that was mock scaled for one minute with an ultrasonic scaler. Instead of water, red 
erythrosine solution was used to represent contamination. Each square containing at least one 
erythrosine spot was considered contaminated and squares were counted twice following the 
exposure by an evaluator. The scaling procedure was repeated ten times by two operators, 
resulting in a total of twenty trials. Mean numbers of contaminated squares were calculated and 
results indicated gross differences based on the operator, making the findings variable based on 
practices of the clinician. Overall, the study found that the HVE attachment device greatly 
reduced detectable aerosol and splatter contamination by as much as 100% in a single trial. These 
results represent a greater than 93% reduction in the average amount of contamination produced 
by the ultrasonic scaler with the HVE attachment when compared to no suction device.34 A 
potential limitation of this study is that it was a small sample size and was completed in vitro, 
making the results difficult to generalize and apply to a clinical environment.  
As an extension of the Harrel et al. study, King et al. published in 1997 an in vivo study 
regarding the reduction of aerosols with an ultrasonic scaler utilizing the same type of engineered 
HVE attachment to the ultrasonic scaler.33 Twelve subjects were enrolled and each subject served 
as his/her own control. Each subject was scaled with an identical ultrasonic unit, insert, power, 
and water setting. Three blood agar plates were placed at a 50° angle and 6-inches from the 
subject’s mouth to collect aerosols. In separate closed-door rooms, ultrasonic instrumentation 
 19
was performed for five minutes on each side of the patient’s mouth, one side with the HVE 
attachment and one side without. After being exposed for 25 minutes, the blood agar plates were 
covered and incubated at 37°C for three days prior to counting CFU.33 Results were in 
concurrence with the study completed in 1996 by Harrel et al. and revealed that the use of a HVE 
attachment significantly reduced aerosols and splatter.33, 34  
The IsoliteTM dryfield illuminator 
 
The IsoliteTM is a device designed to provide isolation, suction, illumination, and 
retraction simultaneously when used by a single operator. The bite-block component of the 
mouthpiece allows for isolation of the maxillary and mandibular quadrants simultaneously so 
that the patient can rest open during the entire dental procedure.8 Due to the relatively new status 
of this product, little research has evaluated the company’s reported benefits of decreased 
procedure time, increased retention rates for restorations and sealants, and reduction of aerosols 
in the operatory. IsoliteTM Systems (Santa Barbara, CA) specifically purports to reduce airborne 
aerosols by up to 65% compared to the saliva ejector, which is of particular interest due to the 
role that aerosols play in the spread of infectious diseases.8, 35 Because the IsoliteTM is designed to 
attach to the high-volume suction hose and previous research has shown that the ultrasonic scaler 
produces the greatest amount of aerosols, it would be prudent to determine how effectively the 
IsoliteTM reduces aerosols and splatter while performing ultrasonic scaling in an actual clinical 
environment.  
An unpublished study by Jacks and Pollard in 2007, compared the IsoliteTM to the HVE 
alone and saliva ejector in an independent laboratory trial and measured the amount of aerosol 
particles that reached the breathing space of the clinician.35 A total of 21 trials were conducted 
and involved mock scaling for two minutes with an ultrasonic scaler.  Scaling was performed on 
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all surfaces of all teeth on a DENTOFORM model. The HVE, saliva ejector, and IsoliteTM were 
compared and each trial was divided into two minute sampling periods: pre-exposure, exposure, 
and post exposure. Aerosols were measured with the DataRAM Real-Time Aerosol Monitor 
every 10 seconds during all phases. Each group was statistically different when compared. The 
IsoliteTM was shown to reduce aerosols by as much as 66% and the HVE by as much as 76% 
when both were compared to the saliva ejector.  The study’s overall recommendation was to alter 
the design of the IsoliteTM mouthpiece to increase airflow, which may deliver a closer reduction 
amount to that of the HVE.35 A limitation of this study is that is was performed in a laboratory 
environment so all of the variables present in a clinical environment were not taken into account.  
 In 2009, Noro et al. published the first study evaluating the IsoliteTM and examined its 
clinical usefulness in a Japanese population.37 Volunteer resident dentists in the Department of 
General Dentistry at Tokyo Dental College Chiba Hospital were utilized as study subjects.  
Subjects were randomly divided into two groups of 15 and paired with an individual from the 
opposite group. In each pair, the subject playing the role of the clinician placed the IsoliteTM into 
the oral cavity of the subject playing the role of the patient and used an air turbine hand piece 
equipped with a dummy bur to simulate tooth preparation for a crown. Following the simulation, 
all subjects completed a survey composed of nine questions regarding their experience with the 
device. Based on the mean overall ratings, the subjects playing the role of the surgeon rated the 
device higher in satisfaction than the patients. The lowest patient ratings were in response to the 
question regarding how the IsoliteTM fits in the mouth, leading to the conclusion that the IsoliteTM 
needed to be altered for a better fit with the Japanese people.37 A drawback of the study was their 
exclusive focus on the Japanese population, making these conclusions difficult to apply to other 
populations. 
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In 2010, a study by Colette et al. assessed patient acceptance of the IsoliteTM during 
sealant placement compared to cotton roll isolation (CRI) while evaluating sealant application 
times.38 A total of 48 children were seen at the pediatric dental clinic at Children’s Hospital in 
Cincinnati, Ohio.   Data on patient acceptance were collected via a verbal survey, consisting of 
nine questions, which asked the patient about his or her experience with both the IsoliteTM and 
CRI. Subjects were randomly assigned to one of two groups, both utilizing the IsoliteTM and CRI 
but alternating which method was used first. The survey was administered following sealant 
placement. The results of the study revealed discomfort was reported with the IsoliteTM for the 
following reasons: stretching of the cheeks, inducing their gag reflex, and high amounts of noise. 
The author concluded that because the participants of the study were all under the age of 11 it 
would be beneficial to utilize older children or adults in future research to further evaluate 
patient acceptance.38 
A study published in November 2012, by Dahlke et al. compared the effectiveness of a 
splatter reduction at an operative site by three groups: the IsoliteTM alone, the HVE with dental 
dam, and the HVE alone in a patient simulated environment.36 During the study, a total of 72 
trials were completed in a closed door operatory and tooth preparation was simulated on a 
typodont manikin during a benchtop exercise. A high-speed hand piece with a carbide bur was 
used to create splatter with a fluorescein dye solution, which was added to the water supply. A 
bulletin board was mounted to surround the typodont head and was used to collect splatter 
emitted from the hand piece and contaminated squares were counted following the conclusion of 
each trial. Each type of dry-field technique was used while tooth prep was simulated on tooth 
numbers 18-20. The control consisted of the HVE alone during simulated tooth preparation. The 
first experimental group consisted of the IsoliteTM set at maximum strength during tooth-
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simulated preparation. The second experimental group consisted of the standard 6-inch dental 
dam with only three holes to isolate the three teeth being prepped. The HVE for the control and 
experimental groups was oriented in an identical position and the IsoliteTM was kept in the same 
position throughout the entire experiment. The study found no significant difference in the 
reduction of splatter between the two experimental devices, but splatter was decreased 
significantly when compared to the HVE alone. The only statistical difference found was that 
when tooth prep was simulated on a more anterior tooth, the HVE with dental dam reduced 
splatter slightly more than the IsoliteTM, likely due to the design of the mouthpiece and the focus 
of evacuation being in the posterior. The conclusions stated that because the IsoliteTM reduced 
aerosols just as well as the HVE with dental dam during tooth preparation, it may be the 
preferred device because of the other benefits it offers, specifically illumination, isolation, 
protection of adjacent soft tissues, assistance in opening the mouth and protecting from 
accidental aspiration.36 The observation that the IsoliteTM was not as effective in the anterior was 
beneficial when identifying possible cofounding variables for the current study.  
Bacterial contamination from ultrasonic scaler aerosol has been well documented in the 
past.3-5, 8,16,31,32,34,35   Developing protocol for the reduction of aerosols during the treatment of 
immunocompromised patients can help protect these patients during dental procedures, such as 
ultrasonic scaling, that create high amounts of potentially infectious aerosols. Presently, there is 
no known research regarding the IsoliteTM’s ability to reduce aerosols or its performance 
compared to other suction devices in an actual clinical environment during use of the ultrasonic 
scaler. Based on the findings of the study, if the IsoliteTM reduces aerosols more effectively 
during ultrasonic scaling than the saliva ejector alone then it may be recommended as a standard 
of care, especially during the treatment of immunocompromised patients.  
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Previous Research Methods to Collect and Quantify Aerosols and Splatter 
  
 A variety of methods have been employed in research to collect and quantify dental 
aerosols and splatter. Historically, these methods have depended on the type of particle being 
studied (aerosol vs. splatter) and/or the type of microbe in questions (anaerobic vs. aerobic). 
Techniques for aerosol and/or splatter collection have ranged from benchtop exercises with 
fluorescein dye to elaborate air sampler devices.  
 The most basic approach to evaluate aerosols and splatter has been the use of benchtop 
studies where dental procedures were simulated and no actual microbes were created or 
measured.5, 21,29,34 In these cases, the primary objective was the testing of aerosol and splatter 
reduction devices instead of collecting and quantifying actual microbes. These studies have 
helped to identify devices that produce as well as reduce the greatest amounts of aerosols and 
splatter.5, 21,29,34 In two separate studies by Harrel et al., aerosol production and reduction were 
evaluated.29, 34 The first of the two studies examined aerosol reduction with an HVE attachment 
to an ultrasonic scaler29 while the subsequent study identified differences in aerosol production 
between hand scaling and various ultrasonic inserts.34 In both studies the coolant water for the 
ultrasonic scaler was replaced with a fluorescein solution and a grid containing one centimeter 
squares surrounded a dentoform model. Squares containing a drop of the fluorescein solution 
were considered contaminated and were counted and recorded.29, 34 A more recent study, which 
used this method while evaluating the IsoliteTM was conducted by Dahlke et al., and compared 
the splatter reduction of the IsoliteTM to the HVE with the rubber dam and HVE alone.36 The 
methods used were similar in that an overlay grid was used to show contaminated squares of 
fluorescein dye. Similar to previous studies, this method proved appropriate for their aims but 
was limited in its inability to collect, identify, and quantify actual microbes.  
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 Some of the earlier studies in the 1940’s and 1950’s were critiqued because of their 
inability to differentiate between viable and non-viable aerosols.39 The earliest published study to 
identify an instrument that was able to collect and count viable airborne particles was in 1958, by 
Ariel Andersen.39 This device is known as the Andersen sampler, consisting of six-stages 
through which the air or aerosol is drawn in by air flow, at a rate of one cubic foot per minute, 
through perforated (400) holes into a Petri dish filled with agar medium to collect the microbes.  
Petri dishes were removed and incubated for an undisclosed amount of time. The way in which 
colonies were counted were not specified but stated as being quantified “in a usual manner” as 
defined in microbiology and in the case of heavily loaded plates, by a dissecting type microscope 
before the colonies were able to merge.39 Although groundbreaking at the time, this method 
proved problematic due to its inability to include splatter as well as its tendency to also include 
dust, molds, yeast, and other particles present in the environment at the time of sampling. This 
study was followed by a very similar study by Larato et al., in 1967, which utilized a similar 
device; the Reyner air sampler.27 An advantage of this study was the specific identification of 
multiple types of bacteria sampled from the air. It was determined that most of the bacteria 
collected were mold or yeast that were either often found in the air or water. The exception to 
this was the identification of alpha streptococcus, which is present in large numbers in the oral 
cavity.  This device faced the same drawbacks as the Andersen air sampler with its inability to 
account for splatter and its tendency to include airborne particles such as mold and yeast because 
of the focused airflow that draws particles into the machine.27 
 As an attempt to address these problems, Micik and Miller et al. in 1969 implemented a 
two-part dental aerobiology study to examine characteristics of bacterial aerosols generated from 
a patient’s mouth during dental procedures.15 These studies utilized a human aerosol test 
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chamber which enclosed the patient’s head and used sealed slots allowing for entry of hands and 
equipment needed to conduct various dental procedures such as hand scaling and cavity 
preparation.  Four Anderson six-stage sieve samplers used to collect aerosols and Petri dishes 
containing heart infused agar were incubated for 48 hours at 37oC. Only aerobic bacteria capable 
of growing on heart infusion agar were counted according to the Andersen method and were 
expressed as CFU/min. A noted limitation of the study was the inability to include splatter and 
anaerobic bacteria. Therefore, in 1971 a subsequent study by Micik and Miller et al. utilized a 
different technique to collect and quantify aerosols.2 This time, the aim was to target splatter and 
a system was engineered to rapidly open and close strategically placed Petri dishes. An apparatus 
was built and installed out of wood battens three feet above the floor radiating one foot below the 
patient’s mouth with the sides extending to the end of the operatory (8 x 10 x 7.5 feet). Petri 
dishes containing heart infused agar were fixed with suction cups to each wooden batten and 
were rotated 360o, opened for exposure, and then closed immediately by rotating the battens in 
the opposite direction. Test dental procedures were performed for 30 seconds to create splatter. 
Once plates had been exposed and closed they were incubated at 48 hours at 37oC and colonies 
were counted. CFU were computed and expressed as CFU/foot.2 A benefit of this study was the 
ability to differentiate from aerosols and splatter. But because of elaborate study design, it would 
be difficult to replicate and reproduce these results.  
 A more common method to collect and quantify aerosols and splatter has been the 
placement of blood agar plates in the vicinity of where aerosols and splatter are being produced. 
This method has shown success in multiple studies in the collection, quantification, and 
identification of specific microbes sampled from the air.13,31-33,30  This approach was used by 
King et al. in 1997 during an attempt to evaluate the effectiveness of an HVE attachment to the 
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ultrasonic scaler at reducing aerosols.33 Prior to initiation of the study, a pilot study was 
conducted and results showed that it took approximately 30 minutes for aerosolized bacteria to 
return to baseline levels. Three blood agar plates were mounted at a 50o angle six-inches from 
the subject’s oral cavity and exposed to the ultrasonic for five minutes and then left often for 25 
minutes following scaling.  Plates were then incubated at 37oC for 72 hours and recorded. There 
was no noted attempt to culture or identify types of bacteria in this study.  Instead, the primary 
outcome was assessed by the quantification of CFU in order to verify the findings of the in-vivo 
Harrel et al. study.33  
 A study conducted in 2006 by Rautemaa et al. took this process a step further and used 
Gram stain to classify aerosolized bacteria.40 In this particular study, aerosol samples were 
collected using horse blood chocolate agar plates. Plates were strategically placed, a set of two in 
six different areas of the operatory, ranging from 0.5 to 2m from the patient’s oral cavity. Each 
plate was opened when treatment was initiated and one plate from each group was closed after 
1.5 hours and the other closed after three hours. The plates were incubated at 37oC for 48 hours 
followed by counting and classifying with Gram stain using a light microscope with 1000x 
magnification. The most common types of bacteria identified were Gram-positive cocci, namely 
viridians streptococci and staphylococci.40 Authors did not state whether plates were incubated in 
an aerobic or anaerobic environment.  
 In 2001, Klyn et al. sought to identify methods to reduce bacteria-containing spray during 
ultrasonic scaling.32 To collect aerosols during ultrasonic scaling, three blood agar plates were 
placed six inches from the oral cavity and one plate was placed two feet from the oral cavity. 
Plates were kept covered until testing and were left open for five additional minutes following 
exposure to the ultrasonic scaler. Plates were immediately incubated at 37oC for 72 hours before 
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being recorded. The organisms collected were aerobic and were recognized as mostly 
staphylococci, which are not considered pathogenic due to their tendency to be found in the 
saliva of healthy adults.   The results of the study were generalized to include pathogenic 
organisms because literature “supports the potential presence of these organisms in aerosols and 
splatter.” 32 It would have been beneficial to culture and identify anaerobic bacteria to confirm 
their presence, which would be constructive when discussing aerosols and the spread of 
infectious disease.   
 As outlined in the above-mentioned studies, there are various methods to collect and 
quantify aerosols and splatter. Those methods that were able to collect bacteria-laden aerosols 
and identify specific microbes were most telling when considering the potential to spread 
infectious diseases in a dental setting. A major downfall of studies that utilized blood agar to 
directly collect splatter and aerosols without the use of an air sampling device was the inability to 
differentiate CFU when there were high counts of aerosols and splatter present. On the other 
hand, studies that did use air-sampling devices were not able to take splatter into account, which 
can be a major source of contamination in the dental office. It seemed prudent to consider an 
alternative method to include both aerosols and splatter while uniformly dispersing the microbes 
so that they could be counted and quantified in a manner that would be as comprehensive as 
possible.
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CHAPTER 3: MATERIALS AND METHODS 
 
Test Device 
 
 The test device utilized for the study was the Isolite™ dryfield illuminator (IsoliteTM 
Systems, Santa Barbara, CA) (Appendix 1). This system was designed to retro-fit onto the high 
volume suction hose and consists of an autoclavable control head with built in LED light and 
disposable mouthpiece. The control head portion of the system can be removed between patients. 
The mouthpiece portion has an integrated bite-block that is continuous with a piece of malleable 
plastic (tongue and cheek shield) that fits in the vestibule and oropharynx area. The tongue/cheek 
shield assists with suction, retraction, and blockage of the throat to help prevent aspiration.  
Control Device 
 
 The positive control for the study was the saliva ejector, a disposable attachment to the 
low-volume suction hose. This device consists of a straight tube of plastic with a standard 4mm 
slot attachment and assists with suction and retraction.  
Ultrasonic Scaling Equipment 
 
 The ultrasonic unit for the study was a 30KHz Cavitron SPS ultrasonic scaler and a 
Dentsply 30K slimline scaling tip (Dentsply Preventive Care, York, PA).  
Lab Equipment 
 
 The liquid medium used to collected aerosols and splatter was Dulbecco’s phosphate 
buffered saline (DPBS) (GIBCO® DPBS, pH 7.4 from invitrogenTM Grand Island, NY 14072). 
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Pre-gassed Brucella agar with 5% sheep Brucella enriched with hemin and vitamin K (BRU by 
Anaerobe Systems, Morgan Hill, CA 95037) was used for the growth of anaerobes.  To assess 
DUWL contamination prior to initiation of the study, R2A Agar (BBL® R2A Agar, from Becton 
Dickinson and Company, Cockeysville, MD 21030) was utilized. A Model D Spiral Plater 
(Spiral SystemTM by Microbiology International, Frederick, MD 21701) was utilized to plate 
replicate aliquots of the dispersed suspension onto Brucella agar for the quantitation of CFU. The 
inoculated Brucella agar was incubated at 37oC in a Coy anaerobic chamber with an atmosphere 
of 5% CO2 / 10% H2 / 85% N2 for up to seven days. A ProtoCOL automated CFU counter 
(ProtoCOL RGB, Model No. 9000, Synoptics Ltd, UK) was utilized to calibrate the hand 
counted CFU by the principal investigator.  
Methods  
 All dental cleanings were conducted in the same enclosed dental operatory, fully 
equipped with high and low volume suction hoses, air/water syringe, an IsoliteTM dryfield 
illuminator, and a DentsplyTM Cavitron Jet. The air in the operatory was set to change over at a 
rate of six to eight times per hour.  Each patient was seated in a supine position during their 
cleaning and was treated by the same clinician. The clinician was a licensed dental hygienist with 
five years of clinical experience and three years of experience with the test device. Each subject 
was asked to refrain from oral hygiene care, such as brushing, flossing or rinsing for 12 hours 
prior to his or her appointment.  
 Participants were English-speaking adults, 18 years of age or older, receiving treatment in 
the General and Oral (GO) Systemic Health clinic located within the School of Dentistry at the 
University of North Carolina Chapel Hill. Participants were recruited by contacting individuals 
of previous Institutional Review Board (IRB) approved studies who still attend the GO Health 
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clinic for a dental hygiene services. Subjects’ rights have been protected by the IRB and written 
informed consent was granted from all subjects. 
 To be included in the study, subjects met the following criteria: (1) had not received 
dental scaling, root planing, or prophylaxis in the last three months (2) absence of tooth 
sensitivity that would prevent use of the ultrasonic scaler, and (3) willing to refrain from oral 
hygiene practices for 12 hours prior to the appointment. Subjects were excluded from the study if 
they presented with the following: (1) presence of a respiratory infection (2) presence of a 
cardiac pacemaker (3) chronic disease with oral manifestations (4) exhibited gross oral pathology 
(5) currently taking antibiotics or steroids, and (6) presence of active infectious diseases such as 
HIV, tuberculosis or Hepatitis B. 
 A telephone script was provided to the scheduling coordinator at the GO Health clinic 
(Appendix 2). As an incentive, participants were offered an oral prophylaxis at no charge. 
Participants who met the inclusion/exclusion criteria were scheduled with the principal 
investigator for a dental cleaning. 
 Prior to initiation of the study methods were tested on a volunteer to establish a protocol 
for the following: placement of Petri dishes, type of medium for microbiological collection, and 
lab procedures for the sampling and quantification of CFU. Two different types of media were 
tested, Brucella agar (solid) and 20 ml of sterile DPBS (liquid).  Three separate plate groups, one 
to the left, right, and center, were placed six inches from the subject’s oral cavity (Appendix 3). 
Each plate group contained one Brucella agar and one plate containing 20ml of DPBS.  
Following the manufacturer’s directions, water lines were flushed prior to the initiation of 
scaling. Each plate was opened to the operatory atmosphere during the entire ultrasonic scaling 
procedure and then closed immediately once scaling was completed. Time spent scaling was 
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recorded as the during exposure period. Each plate was then replaced with a fresh plate for the 
post exposure time period of 35 minutes. Hand scaling was initiated following ultrasonic scaling 
and no other procedures that would create aerosols or splatter were completed (e.g. polishing 
with a prophy cup or air powder polishing). Following the final collection period, Brucella agar 
plates were immediately incubated while the plates containing DPBS were spiral plated onto 
Brucella agar, as detailed in the study procedures. Both types of plates were incubated and CFU 
were counted after 7 days.  After quantifying the CFU on each type of plate, those containing the 
DPBS and plates centered in front of the subject’s oral cavity were found to produce consistently 
higher CFU, providing a more complete representation of the actual infectious load.  
To ensure that CFU collected originated from an oral source an atmospheric baseline of 
aerosols was obtained as well as a baseline of the DUWL bacteria.  To obtain an atmospheric 
baseline, a single Petri dish containing Brucella agar was placed in the center of the closed door 
operatory and uncovered for thirty minutes. The Brucella agar plate was not inoculated and 
instead kept at 37oC and checked after 48 hours, and did not show any growth, indicating a 
negative atmospheric baseline for aerosols. Further, DUWL were tested for the presence of 
bacterial contamination by plating water samples onto R2A agar, which was incubated at room 
temperature and was not enriched. Oral bacteria are unable to grow on this medium, but the 
bacteria characteristically associated with DUWL contamination can. This test was also negative 
for the presence of bacteria. Therefore, it was inferred that any CFU collected originated from 
the treatment subject.  
 Each patient was instructed to refrain from any oral hygiene care for 12 hours prior to the 
study. Upon arrival to their appointment, subjects were given an IRB and Health Insurance 
Portability and Accountability Act (HIPAA) consent form. Once consented, subjects were 
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randomized with the flip of a coin into one of two treatment groups (test device or positive 
control) and the appointment for the oral prophylaxis was initiated. The medical history was 
updated, an oral cancer screening was performed, and a plaque index recorded (Appendix 4). To 
determine the extent of plaque a Modified Greene and Vermilion plaque index was performed.  
Each tooth was given a single score for the facial surface only based on the following criteria:  
 
Score Amount of plaque 
0 No plaque present 
1 Plaque covering not more than one third of the tooth surface 
2 Plaque covering more than one third but less than two thirds of the tooth surface 
 
3 Plaque covering more than two thirds of the tooth surface 
 
Once all teeth were scored a sum was calculated and divided by the total number of teeth present 
to give a number ranging from 0-3, with zero being the lowest possible score and three being the 
highest possible score.  
 Prior to ultrasonic instrumentation, a single Petri dish containing 20ml of DPBS was 
centrally placed six inches from the oral cavity (Appendix 5). At the onset of ultrasonic 
instrumentation the lid to the Petri dish was removed for the duration of ultrasonic scaling and 
exposure time was recorded. On completion of the ultrasonic scaling procedure, the Petri dish 
was re-capped and replaced with a new Petri dish containing fresh 20ml of sterile DPBS. The 
second Petri dish remained open to operatory air for 35 minutes to collect aerosols for the post-
exposure period and was then re-capped. The purpose of keeping the plate open for 35 minutes 
following use of the ultrasonic scaler is based on previous studies which have shown that 
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aerosols settle back to baseline an average of 35 minutes after use of a high speed drill or 
ultrasonic scaler.27, 31,32,41 The remainder of the subjects’ cleaning proceeded without the use of 
any devices that would create aerosols or splatter such as coronal polishing or use of an air 
powder polisher. To prevent cross-contamination of aerosols, only one subject was scheduled per 
day. The operator position was set at 11 o’clock during the entire procedure. In addition, the 
amount of water dispensed and the power settings on the ultrasonic unit were identical for each 
subject, at 50% power and lavage. The dual vacuum levers, which control the suction strength on 
the test device, were kept at 75% for the maxillary and mandibular arches while in use. At the 
completion of their appointment, subjects were asked to fill out a nine item survey with questions 
regarding the suction device used during their appointment to assess patient acceptance 
(Appendix 6). Each subject received the same survey regardless of the device used. Each survey 
question was related to the patient’s comfort and experience with the device used during their 
cleaning. A section for comments was provided for feedback regarding the device used.  
At the end of each collection period, the exposed DPBS samples were aseptically 
transferred to a sterile disposable 50ml centrifuge tube and then transferred to the lab within 
fifteen minutes following the final collection period. Once in the lab the CFU in the solution 
were dispersed by vortexing and then spiral plated to fresh anaerobic Brucella blood agar. The 
spiral plater delivered a spiral gradient at a total volume of 0.049 ml sampled from the 20 ml 
volume of the dispersed inoculum. Recovered CFU/ml of liquid were quantified after incubation. 
All Brucella agar plates were pre-gassed from the manufacturer and kept packaged until ready 
for use. The inoculated Brucella agar was incubated at 37oC in a Coy anaerobic chamber for 
seven days. These conditions permit bacterial species to grow that could only have come from 
the oral cavity such as α-hemolytic streptococci, actinomycetes and strict oral anaerobes. Most 
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environmental bacteria and mold will not grow in this atmosphere or at this temperature. 
Following incubation, Brucella agar plates were counted by the principal investigator and 
recorded onto a data collection form (Appendix 7). Each sample was marked with a number so 
that the principal investigator was blinded as to the device used for each sample when recording 
CFU. 
 Extent of aerosol contamination was determined by counting CFU, which were recorded 
by the principal investigator after plates had incubated for the requisite times. CFU were 
recorded by plate number only and were not linked with participants. The total CFU per surface 
area were determined by multiplying by 20 (volume of liquid) and the inverse of the counted 
dilution. This number would be comparable to the total number of CFU landing on the surface of 
the agar plate without consideration for aggregates. The CFU were counted by the principal 
investigator using a counting grid designed to center over the spiral plate and were compared to 
counts determined by the ProtoCOL automated counter. The grid used by the principal 
investigator consisted of five concentric circles and eight radial lines, which create annular 
segments. These segments are further divided creating a number of marked areas. Each and 
every area marked on the grid corresponds to a known, constant volume of sample deposited on 
the spiral plate. The number of CFU was then divided by the corresponding volume for that 
marked area. Following incubation, plates were inspected by the naked eye and by microscope 
for the following: alpha and beta hemolysis, pigmentation, and morphology.  
All sample counts were expressed as colonies of bacteria per milliliter (CFU/ml) and 
were then transformed to log10 for normalization.  All statistical tests were given an alpha level 
of significance of 0.05. To determine if a difference existed in aerosols and splatter reduction 
between the two device groups a Student t-test was utilized to compare the average log10 CFU 
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collected during ultrasonic scaling in each device group. A Student t-test was also performed to 
assess aerosol and splatter reduction within each device group (from during to post exposure) 
and to determine if there was a significant difference between the two device groups in terms of 
average time spent ultrasonic scaling. Spearman’s correlation coefficient was used to measure 
the relationship between full mouth plaque extent and CFU, as well as location of plaque 
(anterior vs. posterior) and CFU. Survey responses were entered into an Excel spreadsheet and 
analyzed for frequencies following completion of the survey.  
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CHAPTER 4: RESULTS 
 
 A total of fifty-two subjects were enrolled in the study.  Data on two subjects were 
excluded from the data analysis due to an incorrect dilution of the DPBS in their samples. 
Twenty-six subjects were randomized into each treatment group. A majority of subjects in each 
group were female, with 77% in the test group and 76% in the control group. The average age of 
subjects in the test group was 40 compared to 45 in the control group. Maximum, median, and 
minimum tooth counts were also calculated for each group, revealing a maximum of 32 teeth and 
a median of 28 teeth in each group, and a minimum of 24 teeth in the test group and 21 teeth in 
the control group. Subjects within each group represented a range of plaque extent scores, which 
were not statistically different between groups (Table 4.1).  
 To assess for bias, time spent ultrasonic scaling and plaque extent scores were assessed 
between the two groups. A Wilcoxon Rank Sums test revealed that there was not a statistically 
significant difference between the two groups in the average time spent ultrasonic scaling during 
the procedure (P= 0.68). Similarly, a Student t-test revealed there was not a significant difference 
in the average full-mouth plaque extent scores between the two groups (p=0.56). 
Primary Objective  
 There was not a statistically significant difference in aerosol and splatter reduction during 
ultrasonic scaling between the test and control group (p=0.25).  Descriptive statistics of aerosols 
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and splatter collected in both exposure periods are displayed in Table 4.2. The range of aerosols 
and splatter collected during ultrasonic scaling in each group can be compared in Figure 4.1. As 
shown in this figure, the average number of aerosols and splatter collected in the control group 
was approximately log10 3.6 CFU/ml (4,000 CFU/ml) compared to log10 3.3 CFU/ml (2,000 
CFU/ml) in the test group. The range of aerosols and splatter collected in the 35-minute post 
exposure period in each group is displayed in Figure 4.2. As shown in this figure, the average 
number of aerosols and splatter collected in the control group and test groups in the post 
exposure period was approximately log10 2.0 CFU/ml (100 CFU/ml) and log10 1.6 CFU/ml (45 
CFU/ml) respectively. 
 When looking within each device group, there was a significantly sharp decline in 
aerosols and splatter following ultrasonic scaling (p<0.0001), as displayed in Figures 4.3 and 4.4. 
Overall, each group exhibited a maximum amount of aerosol and splatter contamination of 
approximately log10 5.0 CFU/ml (100,000 CFU/ml) during ultrasonic scaling with plates 
exhibiting no growth in the post exposure period. Within the control group (Figure 4.3) the 
average number of aerosols and splatter declined from log10 3.6 CFU/ml (4,000 CFU/ml) to log10 
2.0 CFU/ml
  
(100 CFU/ml) representing an almost 98% reduction. A significant decline was also 
found in the test group (p<0.0001) where the average number of aerosols and splatter declined 
from log10 3.3 CFU/ml (2,000 CFU/ml) to log10 1.6 CFU/ml (45 CFU/ml) representing an almost 
98% reduction, displayed in Figure 4.4.  
 To assess for potential bias, Spearman correlations were performed to assess the 
relationship between plaque extent and aerosols and splatter collected in each device group. 
Within the control group there was a significant positive correlation (p=0.003) between aerosols 
and splatter collected during ultrasonic scaling and full-mouth plaque extent with an R2 value of 
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0.27, displayed in Figure 4.5. When this relationship was assessed in the anterior region a 
significant positive correlation (p<0.0001) was also found with an R2 value of 0.43, displayed in 
Figure 4.6. However, no significant relationship (p=0.201) was found in the posterior region, 
displayed in Figure 4.7. These same relationships were also examined in the test group. When 
assessing full-mouth extent a significant relationship was not found (p=0.087) displayed in 
Figure 4.8. In contrast to the control group, a significant positive correlation was not found in the 
anterior region (p=0.105) with an R2 value of 0.18, displayed in Figure 4.9. In the posterior 
region no correlation was found (p=0.290) with an R2 value of 0.04, displayed in Figure 4.10.  
 All samples were assessed for the presence of oral bacteria.  The types and frequencies of 
identified bacteria types are shown in Table 4.3. The most prominent type of bacteria present 
was alpha hemolytic streptococcus, present in 100% of the samples, followed by: Fusiform 
(64%), black pigmented (26%), beta hemolytic bacteria (20%), Eikenella corrodens (12%), 
Prevotella intermedia (10%), Tannerella forsythia (4%), and Porphyromonas gingivalis (2%).  
Secondary Objective 
 Survey responses indicated that the test device was not well liked. When subjects were 
asked,  “Would you like to have this device used during your next cleaning?” 92% of those in the 
control group said “yes” where only 64% of those in the test group said “yes.” When asked if the 
device made them feel as if they were going to gag, or stretched their cheek and lips, there were 
no subjects that answered “yes” in the control group where a range of 12-20% said “yes” in the 
test group. Table 4.4 displays the percentage of “yes”, “no”, and “don’t know” responses of each 
question, bolding those questions with considerable differences in responses.   
 When examining comments related to their experience 24% in the test group and 28% in 
the control group reported a “good” experience. A more common theme among comments from 
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subjects was related to the size and design of the test device mouthpiece. Specific emic 
expressions regarding the test device related to this theme include:  
• “It does hurt being inserted but once there it’s comfortable.” 
• “It felt only a little bit uncomfortable initially and only made me feel like I was going to 
gag at first.” 
• “Kept the back of my mouth dry, but didn’t really help with the fluids in front. Had more 
dribble down my face and neck than previous traditional suction devices and the same 
sonic cleaner.” 
• “My only negative issue was slight buildup of water at the back of my throat.”  
• “I have a small mouth so it was a lot in my mouth….” 
• “…..I felt a little stretch to the cheeks and lips but this may be normal for inserting for 
comfort/fit….” 
•  “Device made me feel as if not getting enough air (intermittent), [I] needed to take a 
deep breath occasionally.” 
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CHAPTER 5: DISCUSSION 
 
Introduction 
 Due to the amount of contamination that takes place during most dental procedures, it is 
of great importance to minimize the presence of potentially infectious aerosols and splatter as 
much as possible. Minimizing aerosols and splatter during treatment may be one mechanism for 
achieving this goal. 
Key Findings 
The purpose of this study was to compare the effect of the IsoliteTM suction and saliva 
ejector on aerosols and splatter during ultrasonic scaling. Results indicated that there was not a 
significant difference in the average number of aerosols and splatter collected during ultrasonic 
scaling between the two groups tested (p=0.25). However, the amount of contamination taking 
place during ultrasonic scaling, as indicated by high counts (approximately log10 5.0 CFU/ml or 
100,000 log10 CFU/ml) in both groups, is concerning. When considering the saliva ejector only, 
these findings were in agreement with previous studies and confirmed that the saliva ejector was 
not effective at removing aerosols and splatter created during ultrasonic scaling.27, 31,33 It was 
unexpected to find similar amounts of aerosols and splatter collected during ultrasonic scaling in 
the test group due its design to attach to the high-volume suction hose. These findings conflicted 
with the findings of the 2007 Jacks and Pollard study and the 2012 Dahlke et al. study.35,36 Each 
of these studies detected a significant reduction of aerosols when the test device was compared to 
the saliva ejector35 and HVE alone.36  Further, the Dahlke et al. study found the test device to be
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comparable to the HVE with rubber dam at aerosol reduction, except when in the anterior 
region.36  Because the current study was the first of its kind to evaluate the IsoliteTM in regards to 
aerosol/splatter reduction in an actual clinical environment, it was presumed that the addition of 
other variables (e.g. plaque, saliva, patient/operator positioning) contributed to dissimilar 
findings. Therefore, it can be concluded from these studies that although attempts can be made to 
create an environment identical to a clinical environment, it is difficult through bench-top studies 
to capture all of the variables involved in actual clinical studies.  
When aerosol and splatter reduction within each group was assessed, the reduction was 
significant (p<0.0001). A reduction of approximately 98% was seen in both device groups, with 
some samples in the during exposure period containing as much as log10 5.0 CFU/ml (100,000 
CFU/ml) and some samples in the post exposure period containing no growth at all. However, 
this sharp decline of aerosols and splatter cannot be attributed to any properties of the suction 
devices because both suction devices were turned off immediately following ultrasonic scaling. 
This significant decline was thought to be directly related to the air clearance by the air handling 
system of the operatory. Due to the use of a closed-door operatory for the current study, it may 
be beneficial to examine this effect in an open-bay clinical environment.  
The significant relationship between anterior location of plaque and higher counts of 
aerosols and splatter in the control group can likely be explained by the inherent nature of the 
saliva ejector (i.e. to remove saliva not aerosols).  Because the saliva ejector sits in the floor of 
the mouth and suctions out pooled saliva, the aerosols were allowed to escape into the 
environment. In contrast, the IsoliteTM did not show a significant relationship between anterior 
location of plaque and higher counts of aerosols and splatter. This finding can be explained by 
the design of the IsoliteTM mouthpiece, which is able to provide suction in multiple areas of the 
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mouth, allowing it to target aerosols and splatter instead of just saliva alone. This finding is not 
in agreement with the Dahlke et al. study, which found a significant positive correlation between 
increased aerosol contaminations in the anterior region during use of the IsoliteTM.36  
Findings related to microbiological methodology 
 The presence of strict oral bacteria in all samples (e.g. alpha hemolytic streptococci) 
confirmed that the bacteria collected had originated from the oral cavity (saliva and/or plaque) of 
the host and not from the skin or the environment. As detailed in the methods, each sample was 
collected in a liquid medium (DPBS) and spiral plated onto Brucella agar. Utilizing a liquid 
medium instead of a solid medium and vortexing all samples before spiral plating allowed for a 
more complete representation of the actual infectious load. Further, the use of Brucella agar 
enriched with hemin and Vitamin K incubated in an anaerobic chamber excluded the growth of 
bacteria not typically associated with the oral cavity.  
 Previously, the most basic approach to evaluate aerosol and splatter reduction devices has 
been in a simulated clinical environment where no actual bacteria were involved.27, 29,34,38 These 
methods eventually progressed to the collection of aerosols by use of an air sampling machine 
9,15,39   or placement of blood agar plates in the vicinity of the patient’s oral cavity during dental 
treatment.14,31-33,40  A downfall of air sampling devices were their inclusion of environmental 
contaminants and their inability to evaluate splatter, which eventually led to the use of blood agar 
plates. Blood agar plates, although useful for collecting aerosols and platter, can make it difficult 
to differentiate individual microbial colonies when high amounts of aerosols and splatter are 
collected during a single collection period. Further, a majority of studies that utilized blood agar 
plates for collection only allowed incubation to occur for 48-72 hours, which did not give some 
periodontal pathogens long enough to grow. A seven-day incubation period in the current study 
allowed for the growth of black-pigmented bacteria, which were inspected and identified as 
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having morphology consistent with periodontal pathogens (i.e. P.gingivalis and P.intermedia). 
The presence of these anaerobic pathogens is disconcerting due their link to acute bacterial 
endocarditis12 and more commonly, aspiration pneumonia.11 The process of ultrasonic scaling 
almost always involves working sub-gingivally, which disrupts the microbes present in the 
periodontal pocket and aerosolizes it. A benefit not offered by the saliva ejector but reported by 
the IsoliteTM is the protection against aspiration. The IsoliteTM’s mouthpiece provides this benefit 
by wrapping around the back of the mouth and blocking the oropharynx.8 This advantage should 
be considered, especially when working with an immunocompromised population who are more 
susceptible to these infections.  
Secondary Objective 
 When assessing patient acceptance of the test device it was determined that the 
mouthpiece should be modified so that it is less likely to stretch the cheeks and lips during 
insertion and cause gagging. Leading factors to this conclusion were based on the frequency of 
“yes” responses to survey question #’s 2-4 which asked subjects if the suction device used during 
their cleaning made them feel as if they were going to gag and stretched their cheeks and/or lips. 
Moreover, when subjects were asked if they wanted to have that suction device used during their 
cleaning, 92% said “yes” in the control group where only 64% said “yes” in the test group. These 
findings are in direct agreement with two previous studies which evaluated patient acceptance of 
the test device.37,38  It was recommended by Colette et al. to modify and trim the flange portion of 
the mouthpiece to decrease gagging.38 This recommendation along with decreasing the width of 
the bite-block portion may better increase patient acceptance of the test device.  
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CHAPTER 6: CONCLUSIONS 
 
It remains, as recommended by the ADA and CDC, that the HVE, along with proper 
patient positioning, should continue to be used during dental procedures that yield high amounts 
of aerosols and splatter.6, 7 However, due to its design, the test device has been reported to help   
prevent aspiration8 which should be taken into account, especially when treating 
immunocompromised patients. The test device also has various benefits not related to aerosol 
reduction (i.e. isolation, illumination, etc.) and if being used for those reasons it is recommended 
that additional measures be taken to further reduce aerosols and splatter. For example, it would 
be beneficial to follow the ultrasonic scaler with an additional suction device in the anterior 
region while the test device is being used.  Further, preprocedural mouth rinses have been shown 
to reduce bacterial laden aerosols and splatter prior to use of aerosol creating devices42 and 
should therefore be used in instances where aerosols creating devices, such as the ultrasonic 
scaler, will be utilized. In addition to this, removal of gross biofilm would be helpful in reducing 
the patient’s plaque load by having the patient brush before initiating ultrasonic scaling. It is also 
recommended that dental offices and institutional settings consider air clearance as a way to 
further reduce cross-contamination, especially in open-bay clinic environments where aerosols 
have the opportunity to spread much further.  Patient positioning should also be considered when 
optimizing aerosol reduction. A supine patient position was utilized in the current study and 
proper patient positioning should be used whenever possible during aerosol producing 
procedures, as outlined by the ADA and CDC.6, 7  
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Limitations 
A limitation of the current study is the small number of participants in each group when 
analyzing by device. An increased sample size would be beneficial in future studies.  
Future Studies 
Future research conducted in this area should be designed to allow comparison of the IsoliteTM 
and HVE in a randomized clinical trial utilizing the aerosol and splatter collection methods of the 
current study.  
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TABLES 
Table 4.1 
 Descriptive Statistics of Plaque Extent Scores by Group 
Group    Anterior   Posterior   Full Mouth 
      
Control 
n=25   
Mean + s.d.   0.94 + 0.63  0.80 + 0.43  0.87 + 0.48 
Median (Min-Max)           0.80 (0-2.33)            0.75 (0-1.62)          0.68 (0.21-1.93) 
 
Test 
n=25 
Mean + s.d.   0.80 + 0.53  0.79 + 0.41  0.80 + 0.40 
Median (Min-Max)           0.67 (0-2.17)            0.75 (0.25-1.80)        0.68 (0.12-1.59) 
 
p-Value*         0.39        0.32         0.56 
 
*Statistical analysis derived from Student t-test (p<.05) 
 
Table 4.2 
Descriptive Statistics of log10 CFU/ml by Group 
 
 
Group During Exposure 
log10 CFU/ml 
Mean + s.d.  (95% CL) 
Post Exposure 
log10 CFU/ml 
Mean + s.d. (95% CL) 
Control 
(n=25) 
 
 
3.61 + 0.95 (0.74, 3.21) 
 
 
   2.00 + 1.17 (0.91, 1.52) 
 
Test 
(n=25) 
 
3.30 + 0.88 (0.68, 2.94) 1.65 + 1.15 (0.90, 1.17) 
p-value* 
 
0.25 0.29 
*Statistical analysis derived from Student t-test (p<.05) 
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Table 4.3 
Type and Percentage of Bacteria Present Among all Samples 
Bacteria    Total Present           Percent 
             (n=50)    (%) 
      
Alpha Hemolytic Streptococcus        50                100 
Fusiform           32      64 
Black Pigmented          13      26 
Beta Hemolytic             10      20 
E. corrodens            6      12 
P. intermedia            5      10 
T. forsythia            2       4 
P. gingivalis                        1       2    
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Table 4.4    
Survey Questions and Responses 
 
 
Question: Test 
(n=25) 
Control 
 (n=25) 
Response  Y 
% 
N 
% 
DK 
% 
Y 
% 
N 
% 
DK 
% 
1. Was the suction device used during your cleaning   
today comfortable? 
84 16 0 96 4 0 
2. Did the suction device make you feel as if you 
were going to gag? 
20 80 0 0 100 0 
3. Did the suction device stretch your cheeks? 12 88 0 0 100 0 
4. Did the suction device stretch your lip(s)? 20 80 0 0 96 4 
5. Did the suction device cause discomfort during 
your cleaning today? 
16 84 0 4 96 0 
6. Did the suction device make you feel as if you 
were drowning during your cleaning? 
4 96 0 4 96 0 
7. Did the suction device help to keep fluids or 
debris from your face and/or your body during your 
cleaning today? 
60 28 12 76 24 0 
8. Did you feel that the suction device created a lot 
of noise? 
24 76 0 20 80 0 
9. Would you like to have this suction device 
used during your next cleaning? 
64 24 12 92 0 8 
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Figure 4.9 
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APPENDIX 1: TEST DEVICE 
 
 
 
 
 
 
Courtesy of IsoliteTM Systems, Santa Barbara, California 
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APPENDIX 2: IRB APPROVED TELEPHONE SCRIPT 
 
 
Hi, this is     (name)        calling from the GO Health clinic at the UNC Dental School. I am calling 
because you are due for your cleaning and you indicated that you would like to be contacted for any 
upcoming appropriate studies.  We have a study that will be beginning in January. The purpose of the 
study is to determine if aerosols produced during dental cleanings can be reduced when using either a 
high volume suction or low volume suction.  Your participation in the study will involve having your 
teeth cleaned while aerosol samples are collected in a Petri dish (laboratory saucer) filled with a salt-type 
solution (saline buffer).  At the end of the cleaning, you will be asked to fill out a 10 question survey on 
the use of the suction device.  Participation in the study will take approximately 90 minutes and there is 
no charge for participating.  If you choose NOT to participate in the study, this will not affect you getting 
your teeth cleaned in the GO health clinic as a regular patient.  If you would like to participate in the 
study, then I would like to ask you three questions to determine if you are eligible to participate.   
 
1.  Have you taken an antibiotic or steroid within the past week? (If no, then proceed to next question. If 
yes, then they are not eligible to participate in the study). 
 
2. Are you currently undergoing treatment for a respiratory infection? (If no, then proceed to next 
question. If yes, then they are not eligible to participate in the study). 
 
3. Do you currently have a cardiac pacemaker? (If no, then proceed to next question. If yes, then they are 
not eligible to participate in the study). 
 
4.  Are you able to tolerate the use of the ultrasonic scaler while getting your teeth cleaned?  (If yes, then 
proceed to the next section.  If no, then they are not eligible to participate in the study).   
 
 
 
 
Based on your answers to these questions, we will be able to schedule your cleaning with the dental 
hygienist.  We do ask that you refrain from all oral hygiene practices, such as brushing and flossing for 12 
hours prior to your appointment.  
 
Thank you for your time. 
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APPENDIX 3: STUDY DESIGN PHASE 
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APPENDIX 4:  PLAQUE EXTENT DATA FORM 
 
Subject # ___________ 
 
Start Time: 
End Time: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
                
                
32 31 30 29 28 27 26 25 24 23 22 21 20 19 18 17 
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APPENDIX 5: PLACEMENT OF PETRI DISH 
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APPENDIX 6: SURVEY INSTRUMENT 
 
 
Subject Number __________ 
 
Study on the Effect of Suction Devices on Aerosol Production 
Post-treatment Subject Survey 
 
Directions: Please circle the answer that best describes your experience today. 
 
1.  Was the suction device used during your cleaning   Yes  No  Don’t Know 
today comfortable?    
     
2.  Did the suction device make you feel as if you were going Yes  No  Don’t Know 
 to gag?   
       
3.  Did the suction device stretch your cheeks?    Yes  No  Don’t Know 
 
4.  Did the suction device stretch your lip(s)?    Yes  No  Don’t Know 
 
5.  Did the suction device cause discomfort during your   Yes  No  Don’t Know 
cleaning?   
 
6.  Did the suction device make you feel as if you were   Yes  No  Don’t Know 
drowning?   
 
7.  Did the suction device help to keep fluids or debris   Yes  No  Don’t Know 
from your face and/or your body during your cleaning today?    
 
8.  Did you feel that the suction device created a lot of noise?  Yes  No  Don’t Know 
 
9.  Would you like to have this suction device used during Yes No  Don’t Know 
 your next cleaning?   
        
10.  Please provide any additional feedback or comments regarding the device. 
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APPENDIX 7: LAB CFU RECORDING FORM 
 
 
SUBJECT # ________     Bacteria Present:  
 
 
 
 
 
 
 
 
 
 
CFU COUNTS – During use of ultrasonic 
 Plate #1  Plate #2 Plate #3 Average: 
@ 24-48 hrs 
method: 
 
   
@ 72-96 hrs
 
method: 
    
@ 5-7 days
 
method: 
    
CFU COUNTS – Post use of Ultrasonic 
 Plate #1  Plate #2 Plate #3 Average: 
@ 24-48 hrs
 
method: 
 
   
@ 72-96 hrs
 
method: 
    
@ 5-7 days
 
method: 
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